All Stories

  1. Nephrotoxicity associated with aminoglycoside therapy in paediatrics: experiences from a leading referral hospital in Kenya
  2. Impact of COVID-19 pandemic on the utilization and quality of antibiotic use in the primary care setting in England, March 2019–March 2023: a segmented interrupted time series analysis of over 53 million individuals
  3. Impact of the COVID-19 pandemic on the utilisation and quality of antibiotic use in the Scottish primary care setting: a population-based segmented interrupted time-series analysis
  4. Patterns of initial and first‐intensifying antidiabetic drug utilization among patients with type 2 diabetes mellitus in Scotland, 2010–2020: A retrospective population‐based cohort study
  5. Caveats in reporting of national vaccine uptake
  6. Analysis of the use of antibiotics by AWaRe categories during the COVID-19 pandemic in hospitals across Scotland: a national population-based study
  7. Antimicrobial stewardship capacity and antibiotic utilisation practices in the Cape Coast Teaching Hospital, Ghana: A point prevalence survey study
  8. Involving Patients and Clinicians in the Design of Wireframes for Cancer Medicines Electronic Patient Reported Outcome Measures in Clinical Care: Mixed Methods Study
  9. The Disruptive Impact of COVID-19 on the Utilization of Cancer Chemotherapy-Related Healthcare Assistance at the Principal Nationwide Referral Hospital in Kenya
  10. Selling antibiotics without prescriptions among community pharmacies and drug outlets: a simulated client study from Ghana
  11. Estimated indirect costs of haemodialysis versus peritoneal dialysis from a patients’ perspective at an Academic Hospital in Pretoria, South Africa
  12. Quality of ethnicity data within Scottish health records and implications of misclassification for ethnic inequalities in severe COVID-19: a national linked data study
  13. Data Resource Profile: The Hospital Electronic Prescribing and Medicines Administration (HEPMA) National Data Collection in Scotland
  14. Current rates of purchasing of antibiotics without a prescription across sub-saharan Africa; rationale and potential programmes to reduce inappropriate dispensing and resistance
  15. Understanding and reporting odds ratios as rate-ratio estimates in case-control studies
  16. Ethnic inequalities in positive SARS-CoV-2 tests, infection prognosis, COVID-19 hospitalisations and deaths: analysis of 2 years of a record linked national cohort study in Scotland
  17. Assessment of the quality of antimicrobial prescribing among hospitalized patients in a teaching hospital in Ghana: findings and implications
  18. Trends in the Cost of Medicines, Consultation Fees and Clinic Visits in Malaysia’s Private Primary Healthcare System: Employer Health Insurance Coverage
  19. Airport based pharmacies; products, services and challenges essential for patients in a global travel landscape
  20. Involving Patients and Clinicians in the Design of Wireframes for Cancer Medicines Electronic Patient Reported Outcome Measures in Clinical Care: Mixed Methods Study (Preprint)
  21. Corrigendum to “Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications”
  22. Meta‐analysis of Factors Associated with Antidiabetic Drug Prescribing for Type 2 Diabetes Mellitus
  23. Perceptions of and Preparedness for the Application of Pharmacoeconomics in Practice, among Final Year Bachelor of Pharmacy Students in South Africa: A National Cross-Sectional Study
  24. Risk Awareness and Demographic Characteristics Associated With the Use of Sexual Enhancement Supplements Among University Staff: A Cross-Sectional Study in the United Arab Emirates
  25. Evaluation of duration of antibiotic therapy across hospitals in Scotland including the impact of COVID-19 pandemic: a segmented interrupted time series analysis
  26. Real-world effectiveness of systemic anticancer therapy for advanced melanoma in the west of Scotland from 2010 to 2018
  27. The impact of the COVID-19 pandemic on cardiovascular disease prevention and management
  28. Shedding light on community pharmacist–directed point-of-care screening and education for patients with kidney stones: Implications and future research
  29. Ongoing Efforts to Improve Antimicrobial Utilization in Hospitals among African Countries and Implications for the Future
  30. Assessing medication use patterns in patients hospitalised with COVID-19: a retrospective study
  31. Uptake of COVID-19 treatments in Scotland
  32. Effects of the COVID-19 pandemic on secondary care for cardiovascular disease in the UK: an electronic health record analysis across three countries
  33. Access to non-prescription medicines via vending machines: key considerations to help transfer the self-care concept to the next generation while managing safety risks
  34. An umbrella review and meta‐analysis of renin‐angiotensin system drugs use and COVID ‐19 outcomes
  35. Appropriateness of surgical antimicrobial prophylaxis in a teaching hospital in Ghana: findings and implications
  36. Tackling antimicrobial resistance across sub-Saharan Africa: current challenges and implications for the future
  37. A national, multicentre web-based point prevalence survey of antimicrobial use in community healthcare centres across South Africa and the implications
  38. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: A systematic review and meta-analysis
  39. Acceptability and Willingness of UAE Residents to Use OTC Vending Machines to Deliver Self-Testing Kits for COVID-19 and the Implications
  40. Impact of Parental Knowledge and Beliefs on HPV Vaccine Hesitancy in Kenya—Findings and Implications
  41. Characteristics and Management of Children With Suspected COVID-19 Admitted to Hospitals in India: Implications for Future Care
  42. Regional variation in longitudinal trajectories of primary care opioids prescribing across Health Boards in Scotland: a population-based study
  43. Assessing knowledge, attitude and practice of community pharmacists on the pain management and implications in UAE children
  44. Development and Validation of a Tool to Improve Community Pharmacists’ Surveillance Role in the Safe Dispensing of Herbal Supplements
  45. Evaluation of antibiotic prescribing for ambulatory patients seeking primary dental care services in a public hospital in Ghana: a clinical audit study
  46. What patient assessment skills do pharmacist independent prescribers require to prescribe immunomodulators in myeloma?
  47. The impact of the COVID-19 pandemic lockdown measures on the prescribing trends and utilization of opioids in the English primary care setting: segmented-liner regression analysis
  48. Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries
  49. An umbrella review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 outcomes: what do we know so far?
  50. Assessing the management of patients with type 2 diabetes in Bangladesh during pre- and post-COVID-19 era and the implications: A pilot study
  51. Top unresolved ethical challenges and dilemmas faced by community pharmacists in providing pharmaceutical care: Drawing the line between ethical challenges and the quality of the pharmaceutical care
  52. An umbrella review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 outcomes: what do we know so far?
  53. Obesity association with antidiabetic drugs’ prescription among patients with type 2 diabetes mellitus: a systematic review and meta-analysis
  54. The impact of the COVID-19 pandemic lockdown measures on the prescribing trends and utilisation of opioids in the English primary care setting: a segmented-linear regression analysis
  55. Prevalence of bacterial coinfection and patterns of antibiotics prescribing in patients with COVID-19: a systematic review and meta-analysis
  56. An umbrella review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 outcomes: what do we know so far?
  57. Biosimilars are essential for sustainable healthcare systems; however, key challenges remain as seen with long-acting insulin analogues
  58. Barriers and facilitators of adherence to antiretroviral treatment at a public health facility in Ghana: a mixed method study
  59. Management of Children Admitted to Hospitals across Bangladesh with Suspected or Confirmed COVID-19 and the Implications for the Future: A Nationwide Cross-Sectional Study
  60. Access to community pharmacy services for people with disabilities: Barriers, challenges, and opportunities
  61. Opportunities and challenges when using record linkage of routinely collected electronic health care data to evaluate outcomes of systemic anti-cancer treatment in clinical practice
  62. Patients' knowledge and practice on disposal of medicines kept in households in South Africa: Findings and implications
  63. Using Administrative Data from Public Health and Drug Programs
  64. Challenges and Innovations Brought about by the COVID-19 Pandemic Regarding Medical and Pharmacy Education Especially in Africa and Implications for the Future
  65. What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer
  66. Key issues surrounding the management of non-communicable diseases including the management of diabetes post COVID-19 among developing countries with a specific focus on Bangladesh
  67. A national, multicentre web-based point prevalence survey of antimicrobial use and quality indices among hospitalised paediatric patients across South Africa
  68. Retrospective cohort study to evaluate medication use in patients hospitalised with COVID-19 in Scotland: protocol for a national observational study
  69. Use of Sedative‐Hypnotic Medications and Risk of Dementia: A Systematic Review and Meta‐Analysis
  70. Utilisation Trend of Long-Acting Insulin Analogues including Biosimilars across Europe: Findings and Implications
  71. Frequency and determinants of domestic violence against Iranian women during the COVID-19 pandemic: a national cross-sectional survey
  72. Opioids and Gabapentinoids Utilisation and Their Related-Mortality Trends in the United Kingdom Primary Care Setting, 2010–2019: A Cross-National, Population-Based Comparison Study
  73. Pilot Study on the Current Management of Children with COVID-19 In Hospitals in Bangladesh; Findings and Implications
  74. Validity of Pneumonia Severity Assessment Scores in Africa and South Asia: A Systematic Review and Meta-Analysis
  75. Antimicrobial Stewardship Activities in Public Healthcare Facilities in South Africa: A Baseline for Future Direction
  76. Health systems, population and patient challenges for achieving universal health coverage for hypertension in Ghana
  77. Evidence-based public policy making for medicines across countries: findings and implications for the future
  78. Polypharmacy definition and prevalence in heart failure: a systematic review
  79. Current utilisation patterns for long-acting insulin analogues including biosimilars among selected Asian countries and the implications for the future
  80. The Current Situation Regarding Long-Acting Insulin Analogues Including Biosimilars Among African, Asian, European, and South American Countries; Findings and Implications for the Future
  81. A multicentre point prevalence study of antibiotics utilization in hospitalized patients in an urban secondary and a tertiary healthcare facilities in Nigeria: findings and implications
  82. Strategies to Improve Antimicrobial Utilization with a Special Focus on Developing Countries
  83. Activities in Namibia to Limit the Prevalence and Mortality from COVID-19 Including Community Pharmacy Activities and the Implications
  84. Assessment of adherence to pneumonia guidelines and its determinants in an ambulatory care clinic in Ghana: findings and implications for the future
  85. Influence of pharmaceutical services organization on the availability of essential medicines in a public health system
  86. A point prevalence survey of antimicrobial utilisation patterns and quality indices amongst hospitals in South Africa; findings and implications
  87. Development of a web-based application to improve data collection of antimicrobial utilization in the public health care system in South Africa
  88. Potential approaches for the pricing of cancer medicines across Europe to enhance the sustainability of healthcare systems and the implications
  89. Key Issues Surrounding Appropriate Antibiotic Use for Prevention of Surgical Site Infections in Low- and Middle-Income Countries: A Narrative Review and the Implications
  90. Utilisation, Availability and Price Changes of Medicines and Protection Equipment for COVID-19 Among Selected Regions in India: Findings and Implications
  91. Rapid Assessment of the Potential Paucity and Price Increases for Suggested Medicines and Protection Equipment for COVID-19 Across Developing Countries With a Particular Focus on Africa and the Implications
  92. Changes in availability, utilization, and prices of medicines and protection equipment for COVID-19 in an Urban population of Northern Nigeria
  93. Prevalence rate of spontaneously reported adverse events and determinants of serious adverse events amongst three outpatient care settings in ghana: findings and implications
  94. COVID-19, health care and self-medication issues in resource-limited settings: Findings and implications based on experiences in Ghana
  95. Health-Care professionals' knowledge and practice regarding disposal of medicines in primary health-care facilities in South Africa: Impact and implications
  96. The prevalence of medication errors among nursing students: A systematic and meta-analysis study
  97. Rapid Assessment of Price Instability and Paucity of Medicines and Protection for COVID-19 Across Asia: Findings and Public Health Implications for the Future
  98. A systematic review and meta‐analysis of the use of renin‐angiotensin system drugs and COVID‐19 clinical outcomes: What is the evidence so far?
  99. Supporting antimicrobial stewardship in Ghana: evaluation of the impact of training on knowledge and attitudes of healthcare professionals in two hospitals
  100. A multicentre point prevalence survey of hospital antibiotic prescribing and quality indices in the Kurdistan Regional Government of Northern Iraq: The need for urgent action
  101. Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future
  102. Supporting global antimicrobial stewardship: antibiotic prophylaxis for the prevention of surgical site infection in low- and middle-income countries (LMICs): a scoping review and meta-analysis
  103. A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes: What is the evidence so far?
  104. Compliance with South Africa’s Antimicrobial Resistance National Strategy Framework: are we there yet?
  105. Availability and price changes of potential medicines and equipment for the prevention and treatment of COVID-19 among pharmacy and drug stores in Bangladesh; findings and implications
  106. Lessons from the failure of implementing the ‘Better Care Better Value’ prescribing indicator for renin–angiotensin system drugs in England: a qualitative study of general practitioners’ perceptions using behavioural change framework
  107. Ongoing and planned activities to improve the management of patients with Type 1 diabetes across Africa; implications for the future
  108. Evaluation of the prescribing decision support system Synonyms in a primary care setting: a mixed‐method study
  109. Real‐world evaluation of the impact of statin intensity on adherence and persistence to therapy: A Scottish population‐based study
  110. Use of record linkage to evaluate treatment outcomes and trial eligibility in a real‐world metastatic prostate cancer population in Scotland
  111. Translation and Validation of the Farsi Version of the Pain Management Self-Efficacy Questionnaire
  112. Review of Ongoing Activities and Challenges to Improve the Care of Patients With Type 2 Diabetes Across Africa and the Implications for the Future
  113. Antimicrobial point prevalence surveys in two Ghanaian hospitals: opportunities for antimicrobial stewardship
  114. Evaluation of the clinical practice of aminoglycoside use in paediatric patients in Kenya: findings and implications for lower-middle income countries
  115. Fixed dose drug combinations – are they pharmacoeconomically sound? Findings and implications especially for lower- and middle-income countries
  116. A Systematic Review and Meta-Analysis of the Use of Renin-Angiotensin System Blockers and COVID-19 Outcomes: What is the Evidence so Far and the Implications?
  117. Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future
  118. Proactive risk assessment of vincristine use process in a teaching and referral hospital in Kenya and the implications
  119. Pricing of oral generic cancer medicines in 25 European countries; fi ndings and implications
  120. Prescribing trends of inhaler treatments for asthma and chronic obstructive pulmonary disease within a resource-constrained environment in the Scottish national health service: findings and implications
  121. Clinical and economic implications of therapeutic switching of angiotensin receptor blockers to angiotensin-converting enzyme inhibitors
  122. Prevalence of metabolic syndrome among Iranian women with polycystic ovary syndrome: A systematic review and meta-analysis
  123. Adverse effects of chemotherapy and their management in Pediatric patients with Non-Hodgkin’s Lymphoma in Kenya: A descriptive, situation analysis study
  124. Ongoing initiatives within the Scottish National Health Service to affect the prescribing of selective serotonin reuptake inhibitors and their influence
  125. Feasibility of using point prevalence surveys to assess antimicrobial utilisation in public hospitals in South Africa: a pilot study and implications
  126. A Systematic Review and Meta-Analysis of Health Literacy in the Iranian Population: Findings and Implications
  127. Prevalence of depression among Iranian patients with rheumatoid arthritis: a systematic review and meta-analysis
  128. Health-related quality of life in Iranian patients with type 2 diabetes: An updated meta-analysis
  129. The use of probiotics as a supplementary therapy in the treatment of patients with asthma: a pilot study and implications
  130. Antibiotic prescribing patterns at a leading referral hospital in Kenya: A point prevalence survey
  131. Clinical and Financial Implications of Medicine Consumption Patterns at a Leading Referral Hospital in Kenya to Guide Future Planning of Care
  132. Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets
  133. Comparative Effectiveness and Safety of Monoclonal Antibodies (Bevacizumab, Cetuximab, and Panitumumab) in Combination with Chemotherapy for Metastatic Colorectal Cancer: A Systematic Review and Meta-Analysis
  134. Antibiotic consumption and antimicrobial resistance in Poland; findings and implications
  135. Prevalence of poststroke depression in Iranian patients: a systematic review and meta-analysis
  136. Comparison of Zidovudine and Tenofovir Based Regimens With Regard to Health-Related Quality of Life and Prevalence of Symptoms in HIV Patients in a Kenyan Referral Hospital
  137. Trends in the prescribing of antipsychotic medicines in Pakistan: implications for the future
  138. Adequacy of Dialysis in Iranian Patients Undergoing Hemodialysis: A Systematic Review and Meta-Analysis
  139. Validity of World Health Organisation prescribing indicators in Namibia’s primary healthcare: findings and implications
  140. Ongoing activities to optimize the quality and efficiency of lipid-lowering agents in the Scottish national health service: influence and implications
  141. Abstract
  142. Prevalence of depression among Iranian patients under hemodialysis: a systematic review and meta-analysis
  143. Evaluation of antihypertensive adherence and its determinants at primary healthcare facilities in rural South Africa
  144. Pilot study assessing the direct medical cost of treating patients with cancer in Kenya; findings and implications for the future
  145. Recent Initiatives in the Republic of Srpska to Enhance Appropriate Use of Antibiotics in Ambulatory Care; Their Influence and Implications
  146. Point prevalence survey of antibiotic use and resistance at a referral hospital in Kenya: findings and implications
  147. Statin use in Brazil: findings and implications
  148. Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications
  149. Ongoing initiatives in Azerbaijan to improve the use of antibiotics; findings and implications
  150. Assessing Adherence to Antihypertensive Therapy in Primary Health Care in Namibia: Findings and Implications
  151. Prescription patterns and adequacy of blood pressure control among adult hypertensive patients in Kenya; findings and implications
  152. Exploring factors associated with patients’ adherence to antihypertensive drugs among people with primary hypertension in the United Kingdom
  153. Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications
  154. Initiatives to increase the prescribing of low cost generics; the case of Scotland in the international context
  155. The impact of the ‘Better Care Better Value’ prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: longitudinal quasi-experimental d...